Exacerbation requiring ED or hospital visit Weighted mean duration of studies: 31 weeks · people with asthma
It is very uncertain whether sublingual immunotherapy changes exacerbation requiring ED or hospital visit Weighted mean duration… compared with control (very low certainty).
1 finding from 1 review
Quality of life · people with asthma
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events Weighted mean duration of studies: 49 weeks · people with asthma
Sublingual immunotherapy showed no clear difference in serious adverse events Weighted mean duration of studies: 56 weeks compared with control (moderate certainty).
1 finding from 1 review
Exacerbation requiring OCS Weighted mean duration of studies: 25 weeks · people with asthma
It is very uncertain whether sublingual immunotherapy changes exacerbation requiring OCS Weighted mean duration of studies: 58 weeks compared with control (very low certainty).
1 finding from 1 review
All adverse events Weighted mean duration of studies: 60 weeks** · people with asthma
Sublingual immunotherapy leads to higher all adverse events Weighted mean duration of studies: 62 weeks** compared with control (high certainty).
1 finding from 1 review
Bronchial provocation · people with asthma
1 finding from 1 review
ICS use · people with asthma
1 finding from 1 review
Total ocular symptom scores Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Itchy/Gritty eyes Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Watery eyes Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Red eyes Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Eye drops Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Combined symptom‐medication scores Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
Conjunctival immediate allergen sensitivity Symptom scores · patients with allergic conjunctivitis
1 finding from 1 review
increase in the amount of egg that can be tolerated · children with egg allergy
Oral and sublingual immunotherapy may leads to higher increase in the amount of egg that could be tolerated compared with no therapy (low certainty).
1 finding from 1 review
Complete recovery · children with egg allergy
Oral and sublingual immunotherapy may leads to higher complete recovery compared with no therapy (low certainty).
1 finding from 1 review
Numbers of children with serious adverse events · children with egg allergy
1 finding from 1 review
Number of children with mild‐to‐severe adverse events · children with egg allergy
Oral and sublingual immunotherapy may leads to higher number of children with mild‐to‐severe adverse events compared with no therapy (low certainty).
1 finding from 1 review